About Bionavigen
A biopharmaceutical navigation company built on decades of real-world drug development experience.
Who We Are
Bionavigen is a biopharmaceutical navigation company specializing in consulting for the discovery, preclinical development, translational, and regulatory sciences as well as early development of new drugs through smart acquisition.
Our team brings over 30 years of hands-on experience in the biopharmaceutical industry, having contributed to 10 marketed biopharmaceuticals, filed 100+ INDs, and supported 15 BLAs and NDAs through the regulatory process.
We operate as a virtual team of full drug developers — preclinical, clinical, and regulatory experts — providing comprehensive consulting services to pharma and biotech companies, investors, and VC firms.
Our Mission & Differentiators
Real-World Experience
Our consultants have been in the trenches of drug development — from early discovery through regulatory approval — bringing practical, battle-tested expertise to every engagement.
Biologics Specialization
Deep expertise across the full spectrum of biologics: antibodies, ADCs, bispecifics, recombinant proteins, cell and gene therapies, oncolytic viruses, and small molecules.
VC-Backed Acquisition
Actively engaged in the acquisition of clinical-stage biologics and small molecule drugs from pharmaceutical companies, supported by VC investment firms.
Leadership
Dr. Rakesh Dixit, Ph.D., DABT
Founder & Principal Consultant
With over 30 years of experience in biopharmaceutical drug development, Dr. Dixit has led programs resulting in 10 marketed biologics, 100+ INDs, and 15 BLAs/NDAs. His expertise spans preclinical toxicology, translational sciences, and regulatory strategy.
View LinkedIn Profile →